About Nuclear Medicine Equipment
Nuclear medicine equipment are used to diagnose and treat various diseases, such as cancer, cardiovascular diseases, neurological diseases, and drug development. This equipment are used to examine/study different processes including metabolism, tissue blood flow, expression of cell receptors in normal and abnormal cells, neurotransmitter activity, homing, cell trafficking, and apoptosis. These types of equipment are being used extensively in the detection of various kinds of cancer, orthopedic disorders, and other conditions. Nuclear medicine equipment offers the potential to identify diseases that cannot be identified by other techniques and equipment at a comparatively earlier stage. This has led to significant growth of the global nuclear medicine equipment market in the forecast period.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
CAGR | 4.52% |
Competition among existing players is due to the Nuclear Medicine Equipment market share occupied by leading players. The industry leader is engaged in offering innovative and superior quality products to cater to the ever-growing demand for Nuclear Medicine Equipment Market. The companies are implementing strategic activities such as acquisitions and mergers along with collaboration with companies in other industries to aid them in improving sustenance and maintaining their competitive advantage.The Players having a strong hold in the market are Siemens Healthineers, Philips Healthcare, GE Healthcare, and Toshiba Medical Systems Corporation. Analyst at AMA Research estimates that European and United States Players will contribute the maximum growth to Global Nuclear Medicine Equipment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Siemens Healthineers (Germany), Philips Healthcare (Netherlands), GE Healthcare (United States), Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (United States), CMR Naviscan Corporation (United States), SurgicEye GmbH (Germany) and DDD Diagnostics (Denmark) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Bozlu Group (Turkey), SurgicEye GmbH (Germany), Positron Corporation (United States) and TeraRecon, Inc. (United States).
Segmentation Overview
AMA Research has segmented the market of Global Nuclear Medicine Equipment market by Type (Single-Photon Emission Computed Tomography {Standalone, and Hybrid} and Positron Emission Tomography {Standalone, and Hybrid}), Application (Neurology, Oncology, Cardiology and Others (Orthopedics, Urology, Thyroid-related Disorders, and Gastroenterology)) and Region.
On the basis of geography, the market of Nuclear Medicine Equipment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Nuclear Medicine Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Advancement and Development in Radiotracers
Market Growth Drivers:
Increasing in Number of Patients with Cancer and Cardiac Ailments and Investments through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
Challenges:
Increased Adoption of Refurbished Diagnostic Systems
Restraints:
High Cost of Nuclear Medicine Equipment
Opportunities:
Growing Demand for Data Integrated Imaging Systems and High Demand in Emerging Markets
Market Leaders and their expansionary development strategies
In 2022, Mediso Ltd has announced the acquisition of UK-based Bartec Technologies Ltd, specializing in the supply, installation and support of nuclear medicine and molecular imaging equipment and accessories. This profit enhances Mediso's market position in the UK and Ireland. Financial details of the acquisition were not disclosed.
In October 2020, Siemens Healthineers has introduced the Biograph Vision Quadra, a CE-Marked positron emission tomography/computed tomography (PET/CT) scanner that is designed for clinical use as well as translational research – or the application of scientific research to create therapies and procedures that improve health outcomes. and In 2021, Siemens Healthineers introduces the world's first photon counting CT scanner, the Naeotom Alpha. Currently, the system is approved for clinical application in the United States and Europe. Naeotom Alpha excels in all technical factors related to image quality.
The International Atomic Energy Agency (IAEA) has developed guidelines to help nuclear medicine departments adopt operating procedures to minimize the risk of COVID-19 infections among patients, staff, and the public. The guidelines also draw attention to possible shortages of essential imaging radiopharmaceuticals due to global air traffic restrictions.
Key Target Audience
Nuclear Medicine Equipment Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.